Erik Hefti holds a PharmD as well as a Master's and PhD degrees in pharmaceutical science from the University at Buffalo. His research focuses on pediatric pharmacogenomic factors impacting cardiovascular toxicity following cancer chemotherapy and genetic testing utilization to improve healthcare outcomes. His clinical focus involves optimizing pharmacotherapy in patients with genetic disorders. He is the program director and assistant professor of pharmaceutical sciences at Harrisburg University in Harrisburg, PA.
Opportunities and Considerations for Pharmacists as Medical Science Liaisons
April 5th 2020Medical science liaisons are biomedical professionals who are responsible for scientific management of multiple aspects of a product, such as a drug, diagnostic test, or medical device, before and after launch.
Read More